RECURSION PHARMACEUTICALS, INC.
RECURSION PHARMACEUTICALS, INC.
SALT LAKE CITY, UT
Loading...
Price History
Market Data
| Market Cap | 1.79B |
| P/E Ratio | - |
| P/B Ratio | 1.58 |
| EPS | -1.44 |
| Dividend Yield | - |
| D/E Ratio | 0.30 |
| Current Ratio | 5.50 |
| Currency | USD |
Key Financial Metrics
74.68M
Revenue
-644.76M
Net Income
-1.44
EPS (Diluted)
-725.42M
Free Cash Flow
Profitability
Gross Margin
5.0%
Operating Margin
-867.9%
Net Profit Margin
-863.4%
EBITDA
-501.92M
Returns & Efficiency
Return on Assets (ROA)
-43.7%
Return on Equity (ROE)
-57.0%
Dividend Yield
-
EPS
-1.44
Financial Health
Total Assets
1.47B
Total Debt
9.56M
Debt to Equity
0.30x
Current Ratio
5.50
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| Industry | Chemicals & Allied Products |
| HQ | SALT LAKE CITY, UT |
| Fiscal Year | 2025 |
Peers
AMGEN INC
AMGN
177.13B
P/E: --
GILEAD SCIENCES INC
GILD
166.13B
P/E: --
166.13B
P/E: --
BIOGEN IDEC INC.
BIIB
27.90B
P/E: --
BIOGEN INC.
BIIB
27.90B
P/E: --
19.11B
P/E: --
MODERNA, INC.
MRNA
18.38B
P/E: --
Moderna, Inc.
MRNA
18.38B
P/E: --
Quick Links
Financial Statistics
Valuation
Market Cap$1.79B
P/E Ratio (TTM)-
Price to Book1.58
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin5.0%
Operating Margin-867.9%
Net Margin-863.4%
ROE-57.0%
ROA-43.7%
Leverage & Liquidity
Debt to Equity0.30
Current Ratio5.50
Total Debt$9.56M
Total Assets$1.47B
Stockholders' Equity$1.13B
Income Statement (FY 2025)
Revenue$74.68M
Gross Profit$3.73M
Operating Income$-648.13M
Net Income$-644.76M
EPS (Diluted)$-1.44
Cash Flow (FY 2025)
Free Cash Flow$-725.42M
Cash & Equivalents$743.29M
Revenue Growth26.9%
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | 41S RIO GRANDE STREET SALT LAKE CITY, UT 84101 |
| Phone | (385) 269-0203 |
| Incorporated | DE, US |
| EIN | 464099738 |
| Fiscal Year End | 1231 |
| Shares Outstanding | 528.18M |
| Stockholders' Equity | $1.13B |
| Cash & Equivalents | $743.29M |
Recent Filings
View All
ARS
Annual Report to Shareholders
Annual report furnished to shareholders
Filed: 2026-04-30
Local
DEFA14A
Additional Proxy Materials
Additional definitive proxy soliciting materials
Filed: 2026-04-30
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2026-04-30
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-04-30
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-04-22
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-08
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-08
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-08
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-04-07
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-04-07
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-03-25
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-25
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-18
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-03-17
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-11
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | RECURSION PHARMACEUTICALS, INC. |
| Ticker | RXRX |
| Exchange | -- |
| Sector | Manufacturing |
| Industry | Chemicals & Allied Products |
| Headquarters | SALT LAKE CITY, UT |
| Fiscal Year | 2025 |
Financial Summary
| Market Cap | 1.79B |
| Revenue | 74.68M |
| Net Income | -644.76M |
| P/E Ratio | - |
| EPS | -1.44 |
| Net Margin | -863.4% |
| ROE | -57.0% |
| Dividend Yield | - |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...